J
Jan Malte Sinning
Researcher at University Hospital Bonn
Publications - 45
Citations - 3485
Jan Malte Sinning is an academic researcher from University Hospital Bonn. The author has contributed to research in topics: Valve replacement & Aortic valve. The author has an hindex of 22, co-authored 45 publications receiving 2364 citations. Previous affiliations of Jan Malte Sinning include University of Padua & University of Bonn.
Papers
More filters
Journal ArticleDOI
Incidence, Predictors, and Outcomes of Aortic Regurgitation After Transcatheter Aortic Valve Replacement: Meta-Analysis and Systematic Review of Literature
Ganesh Athappan,Eshan Patvardhan,E. Murat Tuzcu,Lars G. Svensson,Pedro A. Lemos,Chiara Fraccaro,Giuseppe Tarantini,Jan Malte Sinning,Georg Nickenig,Davide Capodanno,Corrado Tamburino,Azeem Latib,Antonio Colombo,Samir R. Kapadia +13 more
TL;DR: The authors in this paper found that moderate or severe aortic regurgitation was more common with use of the CoreValve (16.0% vs. 9.1%, p = 0.005).
Journal ArticleDOI
Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
Benedikt Schrage,Karim Ibrahim,Tobias Loehn,Nikos Werner,Jan Malte Sinning,Federico Pappalardo,Marina Pieri,Carsten Skurk,Alexander Lauten,Ulf Landmesser,Ralf Westenfeld,Patrick Horn,Matthias Pauschinger,Dennis Eckner,Raphael Twerenbold,Peter Nordbeck,Tim Salinger,Peter Abel,Klaus Empen,Mathias Busch,Stephan B. Felix,Jan Thorben Sieweke,Jacob E. Møller,Nilesh Pareek,Jonathan Hill,Philip MacCarthy,Martin Bergmann,José P.S. Henriques,Sven Möbius-Winkler,P. Christian Schulze,Taoufik Ouarrak,Uwe Zeymer,Steffen Schneider,Stefan Blankenberg,Holger Thiele,Andreas Schäfer,Dirk Westermann +36 more
TL;DR: In this retrospective analysis of patients with AMI-CS, the use of an Impella device was not associated with lower 30-day mortality compared with matched patients from the IABP-SHOCK II trial treated with an IABp or medical therapy.
Journal ArticleDOI
Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry
Henrique Barbosa Ribeiro,Henrique Barbosa Ribeiro,Josep Rodés-Cabau,Philipp Blanke,Jonathon Leipsic,Jong Kwan Park,Vinayak Bapat,Raj Makkar,Matheus Simonato,Matheus Simonato,Marco Barbanti,Joachim Schofer,Sabine Bleiziffer,Azeem Latib,David Hildick-Smith,Patrizia Presbitero,Stephan Windecker,Massimo Napodano,Alfredo Giuseppe Cerillo,Mohamed Abdel-Wahab,Didier Tchetche,Claudia Fiorina,Jan Malte Sinning,Mauricio G. Cohen,Mayra Guerrero,Brian Whisenant,Fabian Nietlispach,José Honório Palma,José Honório Palma,Luis Nombela-Franco,Arend de Weger,Malek Kass,Fabio Sandoli de Brito,Pedro A. Lemos,Ran Kornowski,John G. Webb,Danny Dvir,Danny Dvir +37 more
TL;DR: Coronary obstruction following aortic ViV procedures is a life-threatening complication that occurred more frequently in patients with prior stentless or stented bioprostheses with externally mounted leaflets and in those with a short VTC.
Journal ArticleDOI
Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death
Ander Regueiro,Axel Linke,Azeem Latib,Nikolaj Ihlemann,Marina Urena,Thomas Walther,Oliver Husser,Howard C. Herrmann,Luis Nombela-Franco,Asim N. Cheema,Hervé Le Breton,Stefan Stortecky,Samir R. Kapadia,Antonio L. Bartorelli,Jan Malte Sinning,Ignacio J. Amat-Santos,Antonio J. Muñoz-García,Stamatios Lerakis,Enrique Gutiérrez-Ibañes,Mohamed Abdel-Wahab,Didier Tchetche,Luca Testa,Hélène Eltchaninoff,Ugolino Livi,Juan C. Castillo,Hasan Jilaihawi,John G. Webb,Marco Barbanti,Susheel Kodali,Fabio Sandoli de Brito,Henrique Barbosa Ribeiro,Antonio Miceli,Claudia Fiorina,Guglielmo Mario Actis Dato,Francesco Rosato,Vicenç Serra,Jean Bernard Masson,Harindra C. Wijeysundera,José Armando Mangione,Maria Cristina Ferreira,Valter Correa Lima,Luiz A. Carvalho,Alexandre Abizaid,Marcos Antonio Marino,Vinicius Esteves,Julio Andrea,Francesco Giannini,David Messika-Zeitoun,Dominique Himbert,Won-Keun Kim,Costanza Pellegrini,Vincent Auffret,Fabian Nietlispach,Thomas Pilgrim,Eric Durand,John Lisko,Raj Makkar,Pedro A. Lemos,Martin B. Leon,Rishi Puri,Alberto San Roman,Alec Vahanian,Lars Søndergaard,Norman Mangner,Josep Rodés-Cabau +64 more
TL;DR: Among patients undergoing TAVR, younger age, male sex, history of diabetes mellitus, and moderate to severe residual aortic regurgitation were significantly associated with an increased risk of infective endocarditis.
Journal ArticleDOI
Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Study.
Benedikt Schrage,Peter Moritz Becher,Alexander M. Bernhardt,Hiram G. Bezerra,Stefan Blankenberg,Stefan Brunner,Pascal Colson,Gaston A Cudemus Deseda,Salim Dabboura,Dennis Eckner,Matthias Eden,Ingo Eitel,Derk Frank,Norbert Frey,Masaki Funamoto,Alina Goßling,Tobias Graf,Christian Hagl,Paulus Kirchhof,Danny Kupka,Ulf Landmesser,Jerry Lipinski,Mathew S Lopes,Nicolas Majunke,Octavian Maniuc,Daniel Mcgrath,Sven Möbius-Winkler,David A. Morrow,Marc Mourad,Curt Noel,Peter Nordbeck,Martin Orban,Federico Pappalardo,Federico Pappalardo,Sandeep M. Patel,Matthias Pauschinger,Vittorio Pazzanese,Hermann Reichenspurner,Marcus Sandri,P. Christian Schulze,Robert H. G. Schwinger,Jan Malte Sinning,Adem Aksoy,Carsten Skurk,Lukasz Szczanowicz,Holger Thiele,Franziska Tietz,Anubodh S. Varshney,Lukas Wechsler,Dirk Westermann +49 more
Abstract: Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used to treat cardiogenic shock. However, VA-ECMO might hamper myocardial recovery. The Impella unloads the le...